Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [21] Study on the clinical efficacy of 14-day vonoprazan-based triple regimen in obese patients with Helicobacter pylori infection
    Li, Zhenxing
    Yan, Kunfeng
    Dai, Xiaorong
    Rong, Weiwei
    JOURNAL OF CHEMOTHERAPY, 2024,
  • [22] Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen
    Shinozaki, Satoshi
    Osawa, Hiroyuki
    Sakamoto, Hirotsugu
    Hayashi, Yoshikazu
    Kobayashi, Yasutoshi
    Miura, Yoshimasa
    Lefor, Alan Kawarai
    Yamamoto, Hironori
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2018, 34 (08) : 456 - 460
  • [23] Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
    Kakiuchi, Toshihiko
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes
    Suzuki, Sho
    Gotoda, Takuji
    Takano, Chika
    Horii, Toshiki
    Sugita, Tomomi
    Ogura, Kanako
    Ichijima, Ryoji
    Kusano, Chika
    Ikehara, Hisatomo
    HELICOBACTER, 2021, 26 (06)
  • [25] Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
    Saito, Yoshimasa
    Konno, Kaho
    Sato, Moeka
    Nakano, Masaru
    Kato, Yukako
    Saito, Hidetsugu
    Serizawa, Hiroshi
    CANCERS, 2019, 11 (01):
  • [26] Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study
    Kakiuchi, Toshihiko
    Matsuo, Muneaki
    Endo, Hiroyoshi
    Sakata, Yasuhisa
    Esaki, Motohiro
    Noda, Takahiro
    Imamura, Ichiro
    Hashiguchi, Kazutoshi
    Ogata, Shinichi
    Fujioka, Yasuhiko
    Hanada, Keiichiro
    Fukuda, Kayoko
    Yoshimura, Masaya
    Kajiwara, Tetsuro
    Yamamoto, Kentaroh
    Yamaguchi, Daisuke
    Kawakubo, Hiroharu
    Matsunaga, Takuya
    Sumino, Michihiro
    Matsunaga, Keiji
    Muro, Eriko
    Watanabe, Akira
    Fujimoto, Kazuma
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (03) : 196 - 204
  • [27] Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin
    Ono, Shoko
    Kato, Mototsugu
    Nakagawa, Soichi
    Mabe, Katsuhiro
    Sakamoto, Naoya
    HELICOBACTER, 2017, 22 (03)
  • [28] Seven-day vonoprazan-based triple therapy as first-line Helicobacter pylori treatment in comparison with extended sequential therapy
    Chiu, Yu-Tse
    Lee, Fu-Jen
    Kuo, Chen-Ya
    Lin, Yang-Chao
    Liang, Kai-Shun
    Tseng, Liang-Wei
    Chen, Yu-Tsung
    Chang, Chi-Yang
    JGH OPEN, 2023, 7 (02): : 105 - 109
  • [29] Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Helicobacter pylori Infection
    Liu, Ligang
    Nahata, Milap C.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (10) : 1185 - 1197
  • [30] Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials
    Yang, Chen
    Li, Sai
    Huang, Taoyang
    Lin, Hongju
    Jiang, Zhihui
    He, Yongyang
    Yuan, Junjie
    An, Huijie
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) : 897 - 904
12345